The blood collection devices market is expected to register a CAGR of 6.5% during the forecast period. In 2023, the market valuation is expected to be at US$ 7.7 billion. By 2033, the figures are expected to cross US$ 14.4 billion.
Key factors which might surge the market growth are:
The key blood collection device market trends show that the demand for effective blood collection has increased as the incidence of infectious illnesses rises. Surging cases of hepatitis B (HBV), hepatitis C (HCV), human immunodeficiency virus (HIV), malaria, syphilis, and brucellosis are expected to drive market growth.
The global burden of chronic illnesses is steadily rising. Cardiovascular disease is responsible for about half of all chronic disease fatalities (CVD). According to the American Heart Association, the prevalence of CVD in the United States is expected to rise to 40.5% by 2030.
Lifestyle disorders are becoming common throughout the world, especially in developing nations. Health checks are becoming more popular on a personal level as well as in the workplace for employee well-being. As blood tests are broadly used to identify various disorders, this will be beneficial to market growth.
In comparison to the whole-blood collection, capital investments in automated blood collection utilizing apheresis systems are quite significant for blood banks. Devices are priced between US$ 45,000 and US$ 55,000 on average. As a result, smaller blood banks and hospitals avoid this method of blood collection.
Therapeutic apheresis is also quite expensive, as it involves the cost of disposables, which ranges from US$ 1,500 to US$ 3,000 per patient. Because of their high prices, automated blood collection items are not as widely used as manual blood collection systems in nations like China and India. The total expansion of the blood collection equipment market is being stifled as a result of this.
These medical equipment and storage devices are frequently unable to acquire appropriate samples in DVA patients, resulting in many efforts to collect blood. This raises the danger of anemia in patients as well as the chance of blood-borne diseases being transmitted to nurses and phlebotomists for painless blood collection.
Thus, new hematology tube designs that facilitate capillary blood collection have been devised, minimizing the likelihood of collection and processing mistakes in DVA patients. A vein lighting and visualization technique called a vein finder is also used to help healthcare personnel discover a healthy vein for venipuncture.
North America is expected to be the dominant market for blood collection devices. The surging geriatric population, prevalence of chronic disease, and technological advancements in blood collection devices are the factors driving the market growth.
| Attributes | Value |
|---|---|
| Blood Collection Devices Market Value (2022) | US$ 6.8 billion |
| Blood Collection Devices Market Expected Value (2023) | US$ 7.7 billion |
| Blood Collection Devices Market Forecast Value (2033) | US$ 14.4 billion |
| Blood Collection Devices Market Expected CAGR (2023 to 2033) | 6.5% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
An increase in chronic illnesses is expected to surge the market growth. The inception of new kinds of viruses which have been impacting human health is expected to present massive prospects for these medical devices. However, the introduction of new medical devices as a result of the upgradation of medical infrastructure has led to lukewarm sales. The supply chain disruption as well has led to the reduction of anticipated CAGR as compared to the historical CAGR. While the historical CAGR for the market was 9.2%, the anticipated CAGR is 6.5%.
The difficulty and expenses of storing and delivering entire blood samples are enormous. Whole blood must be utilized or preserved and kept under stringent temperature and environmental conditions for analysis or other purposes after it is collected. If blood samples in blood drawing devices are not chilled or frozen, their properties begin to alter within hours of collection.
As blood components decay quickly, maintaining their stability is critical. Prolonged exposure to ambient temperatures can drastically alter the results of any analysis on such samples. As a result, medical organizations all around the world have developed blood storage, packing, and shipping protocols.
The blood samples stored in containers should only be kept chilled for 42 days, according to the United States Food and Drug Administration. It is understood, however, that some changes in the blood samples may occur throughout this time.
The National Institute of Health and Welfare in Finland ruled that whole blood samples should only be kept chilled at 4° C for up to seven days before being discarded.
Principal Consultant
| Region | North America |
|---|---|
| Country | United States |
| CAGR (2023 to 2033) | 6.3% |
| Region | Europe |
|---|---|
| Country | United Kingdom |
| CAGR (2023 to 2033) | 5.5% |
| Region | Asia Pacific |
|---|---|
| Country | China |
| CAGR (2023 to 2033) | 5.9% |
| Region | Asia Pacific |
|---|---|
| Country | Japan |
| CAGR (2023 to 2033) | 5% |
| Region | Asia Pacific |
|---|---|
| Country | South Korea |
| CAGR (2023 to 2033) | 4.5% |
Heart disease is believed to be the leading cause of death in the United States. Based on the data released by the Centers for Disease Control and Prevention, about 697,000 people died from heart disease in the United States. This is nearly 1 in 5 deaths. Blood collection devices are mainly used to find the cholesterol level in heart patients.
| Attributes | Details |
|---|---|
| United States Market Expected Size (2033) | US$ 5.1 billion |
| United States Market Absolute Dollar Growth | US$ 2.3 billion |
| CAGR % 2017 to 2022 | 10.8% |
The medical sector in the United States is also undergoing tremendous technological advancements, which might be visible in the blood collection devices as well. These factors are expected to surge the sales of blood collection devices in the nation.
In the United Kingdom, many people are suffering from cerebrovascular disease. The blood sample collection is very crucial, as only a small amount of blood is needed to identify the primary factors. As cerebrovascular disease has got to do with brain surgery, blood collection devices become a by-default choice. This is because these extract a small quantity of blood.
| Attributes | Details |
|---|---|
| United Kingdom Market Expected Size (2033) | US$ 606 million |
| United Kingdom Market Absolute Dollar Growth | US$ 252.9 million |
| CAGR % 2017 to 2022 | 9.8% |
There are lots of people who suffer from dementia in the United Kingdom. Thus, the usage of blood collection devices becomes crucial for dementia patients as well.
A massive amount of diabetic patients present huge opportunities in front of the market. As per the recent survey conducted by Statista, more than 141 million people suffer from diabetes in China as of 2022. The numbers are expected to increase owing to the prevalence of a sedentary lifestyle. Blood collection devices are highly preferred due to their ability to collect small quantities of blood at a given time.
| Attributes | Details |
|---|---|
| China Market Expected Size (2033) | US$ 1 billion |
| China Market Absolute Dollar Growth | US$ 448.9 million |
| CAGR % 2017 to 2022 | 10.4% |
There has also been an increase in patients with cardiovascular diseases in the region. As per recent reports, cardiovascular disease is the leading cause of death in China. This as well is expected to boost the market growth during the forecast period.
Several people in Japan are prone to lung disease. Japan ranks fourth in lung cancers and fifth in lung diseases in the world. The doctors make use of blood collection devices to keep a check on the important parameters while the patients undergo surgery.
| Attributes | Details |
|---|---|
| Japan Market Expected Size (2033) | US$ 844.6 million |
| Japan Market Absolute Dollar Growth | US$ 325.7 million |
| CAGR % 2017 to 2022 | 9.3% |
The country is also meant for numerous stroke patients. The purpose of the blood collection devices remains the same. An increase in stroke patients is expected to accelerate the market growth during the forecast period.
South Korea has been witnessing an increase in the number of cancer cases. Based on the statistics released by ‘Cancer Research and Treatment’, South Korea had 3,909.3 cancer patients per 100,000 people. The numbers are huge compared to lots of other countries. Blood collection devices are highly relevant while treating cancer patients.
| Attributes | Details |
|---|---|
| South Korea Market Expected Size (2033) | US$ 510 million |
| South Korea Market Absolute Dollar Growth | US$ 182.4 million |
| CAGR % 2017 to 2022 | 8% |
South Korea is also meant for having a sophisticated healthcare infrastructure. Thus, a lot of key players are working to develop technologically advanced blood collection devices. In September 2022, a group of scientists in South Korea developed a portable, simple-to-use, and self-pressure-driven blood plasma separation device. These work along with rapid diagnostic test kits as well. Such innovations are expected to surge the market share.
| Segment | Product Type |
|---|---|
| Attributes | Blood Collection Tubes |
| CAGR (2017 to 2022) | 9% |
| CAGR (2023 to 2033) | 6.2% |
| Segment | End User |
|---|---|
| Attributes | Diagnostic and Pathology Laboratories |
| CAGR (2017 to 2022) | 8.8% |
| CAGR (2023 to 2033) | 6.2% |
Blood collection tubes account for the dominant market share. They act as whole blood collection tubes, coagulation tubes, ESR tubes, EDTA tubes, glucose tubes, serum-separating tubes, plasma-separating tubes, and heparin tubes. Blood collection tubes are made more user-specific by adding different types of additives required for various purposes.
Clot activators are used for accelerating the blood clotting process in tubes and anticoagulants are used for preventing blood from clotting in normal conditions. The availability of vacuum and non-vacuum tubes is expected to further surge the market share.
The diagnostic and pathology laboratories are expected to hold the leading market share. These facilities are mainly involved in collecting blood samples and identifying the cause of the disease. They are also collaborating with large government and private hospitals which has led to an increase in the market share. In the current times, diagnostic and pathology laboratories are sending their agents to the patient’s house to collect blood samples. These factors are expected to surge the market share of the segment during the forecast period.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Some start-ups have developed devices that can detect colorectal cancer in its early stages. They have developed a simple blood test, which is cost-effective, minimally invasive, and requires no medical infrastructure. They identify the presence of multiple protein biomarkers for identifying colorectal cancer in blood samples.
Droplite: The Spanish start-up reduces time in testing blood samples through its LOC device. By combining optics, nanotechnology, and micro fluids with biology, the start-up has created a medical device that analyzes fertility, allergy, disease, and veterinary-based issues. Through a drop of blood, the device analyzes immunoassay test cartridges in ten minutes, thereby eliminating the need for tests.
The market players operating in the market are working in the gene therapies space. They are formulating new strategies to develop and commercialize advanced therapies. In December 2022, Cardinal Health’s highly innovative cell and gene therapy was recognized by the innovations issue of PM360.
Key developments in the market:
| Company | Description |
|---|---|
| Greiner | Greiner is a global leader in plastic and foam solutions. With a culture based on trust, responsibility, and mutual respect, the company employs more than 11,000 people in 33 countries. The company operates on the values of openness, appreciation, reliability, and striving for excellence. These values make the company calculable for the employees and the environment as well. |
| Haematonics Corporation | Haematonics Corporation works to drive greater possibilities and meaningfully advance healthcare. The company has been developing innovative medical technology products and services, which improve the quality, effectiveness, and efficiency of care. Haematonics Corporation believes in building a collaborative, performance-driven culture that attracts the best talent. |
| Cardinal Health | Cardinal Health believes in embracing differences to drive the best outcomes. Cardinal Health’s relentless focus on DE&I helps the company perform better, and makes it more innovative. This consequently allows them to solve a given problem more creatively. The Employee Resource Groups are aligned with the company’s businesses and help foster an inclusive and engaged workforce. |
Other key players profiled: Quest Diagnostics, Sarstedt AG & Co. KG
This market is estimated to reach US$ 14.4 billion by 2033.
During 2017 to 2021, the market grew at a CAGR of 6.5%.
During 2017 to 2021, the market grew at a CAGR of 9.2%.
An increase in accidents and trauma cases drives the market.
The blood collection tubes hold high revenue potential.
1. Executive Summary | Blood Collection Devices Marke
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Type, 2017 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2023 to 2033
5.3.1. Blood Collection Tubes
5.3.2. Needles & Syringes
5.3.3. Blood Bags
5.3.4. Blood Collection Systems/Monitors
5.3.5. System Type
5.3.6. Lancets
5.3.7. Others
5.4. Y-o-Y Growth Trend Analysis By Type, 2017 to 2022
5.5. Absolute $ Opportunity Analysis By Type, 2023 to 2033
6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2017 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033
6.3.1. Hospitals, Ambulatory Surgical Centre & Nursing Homes
6.3.2. Blood Bank
6.3.3. Diagnostic & Pathology Laboratories
6.3.4. Others
6.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2022
6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Method
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By Method , 2017 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Method , 2023 to 2033
7.3.1. Manual Blood Collection
7.3.2. Automated Blood Collection
7.4. Y-o-Y Growth Trend Analysis By Method , 2017 to 2022
7.5. Absolute $ Opportunity Analysis By Method , 2023 to 2033
8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Million) Analysis By Application, 2017 to 2022
8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033
8.3.1. Diagnostic
8.3.2. Therapeutic
8.4. Y-o-Y Growth Trend Analysis By Application, 2017 to 2022
8.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033
9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region
9.1. Introduction
9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2022
9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. Asia Pacific
9.3.5. Middle East and Africa
9.4. Market Attractiveness Analysis By Region
10. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. USA
10.2.1.2. Canada
10.2.2. By Type
10.2.3. By End User
10.2.4. By Method
10.2.5. By Application
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Type
10.3.3. By End User
10.3.4. By Method
10.3.5. By Application
10.4. Key Takeaways
11. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Brazil
11.2.1.2. Mexico
11.2.1.3. Argentina
11.2.1.4. Rest of Latin America
11.2.2. By Type
11.2.3. By End User
11.2.4. By Method
11.2.5. By Application
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Type
11.3.3. By End User
11.3.4. By Method
11.3.5. By Application
11.4. Key Takeaways
12. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Germany
12.2.1.2. Italy
12.2.1.3. France
12.2.1.4. United Kingdom
12.2.1.5. Spain
12.2.1.6. BENELUX
12.2.1.7. Russia
12.2.1.8. Rest of Europe
12.2.2. By Type
12.2.3. By End User
12.2.4. By Method
12.2.5. By Application
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Type
12.3.3. By End User
12.3.4. By Method
12.3.5. By Application
12.4. Key Takeaways
13. Asia Pacific Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.1.4. India
13.2.1.5. Thailand
13.2.1.6. Rest of Asia Pacific
13.2.2. By Type
13.2.3. By End User
13.2.4. By Method
13.2.5. By Application
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Type
13.3.3. By End User
13.3.4. By Method
13.3.5. By Application
13.4. Key Takeaways
14. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. Türkiye
14.2.1.3. South Africa
14.2.1.4. Rest of Middle East and Africa
14.2.2. By Type
14.2.3. By End User
14.2.4. By Method
14.2.5. By Application
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Type
14.3.3. By End User
14.3.4. By Method
14.3.5. By Application
14.4. Key Takeaways
15. Key Countries Market Analysis
15.1. USA
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2022
15.1.2.1. By Type
15.1.2.2. By End User
15.1.2.3. By Method
15.1.2.4. By Application
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2022
15.2.2.1. By Type
15.2.2.2. By End User
15.2.2.3. By Method
15.2.2.4. By Application
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2022
15.3.2.1. By Type
15.3.2.2. By End User
15.3.2.3. By Method
15.3.2.4. By Application
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2022
15.4.2.1. By Type
15.4.2.2. By End User
15.4.2.3. By Method
15.4.2.4. By Application
15.5. Argentina
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2022
15.5.2.1. By Type
15.5.2.2. By End User
15.5.2.3. By Method
15.5.2.4. By Application
15.6. Germany
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2022
15.6.2.1. By Type
15.6.2.2. By End User
15.6.2.3. By Method
15.6.2.4. By Application
15.7. Italy
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2022
15.7.2.1. By Type
15.7.2.2. By End User
15.7.2.3. By Method
15.7.2.4. By Application
15.8. France
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2022
15.8.2.1. By Type
15.8.2.2. By End User
15.8.2.3. By Method
15.8.2.4. By Application
15.9. United Kingdom
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2022
15.9.2.1. By Type
15.9.2.2. By End User
15.9.2.3. By Method
15.9.2.4. By Application
15.10. Spain
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2022
15.10.2.1. By Type
15.10.2.2. By End User
15.10.2.3. By Method
15.10.2.4. By Application
15.11. BENELUX
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2022
15.11.2.1. By Type
15.11.2.2. By End User
15.11.2.3. By Method
15.11.2.4. By Application
15.12. Russia
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2022
15.12.2.1. By Type
15.12.2.2. By End User
15.12.2.3. By Method
15.12.2.4. By Application
15.13. China
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2022
15.13.2.1. By Type
15.13.2.2. By End User
15.13.2.3. By Method
15.13.2.4. By Application
15.14. Japan
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2022
15.14.2.1. By Type
15.14.2.2. By End User
15.14.2.3. By Method
15.14.2.4. By Application
15.15. South Korea
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2022
15.15.2.1. By Type
15.15.2.2. By End User
15.15.2.3. By Method
15.15.2.4. By Application
15.16. India
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2022
15.16.2.1. By Type
15.16.2.2. By End User
15.16.2.3. By Method
15.16.2.4. By Application
15.17. Thailand
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2022
15.17.2.1. By Type
15.17.2.2. By End User
15.17.2.3. By Method
15.17.2.4. By Application
15.18. GCC Countries
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2022
15.18.2.1. By Type
15.18.2.2. By End User
15.18.2.3. By Method
15.18.2.4. By Application
15.19. Türkiye
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2022
15.19.2.1. By Type
15.19.2.2. By End User
15.19.2.3. By Method
15.19.2.4. By Application
15.20. South Africa
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2022
15.20.2.1. By Type
15.20.2.2. By End User
15.20.2.3. By Method
15.20.2.4. By Application
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Type
16.3.3. By End User
16.3.4. By Method
16.3.5. By Application
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Quest Diagnostics
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.2. Cardinal Health
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.3. Greiner AG
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.4. Haematonics corporation
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.5. Sarstedt AG & Co. KG
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.6. Fresenius Kabi
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.7. Grifols S.A.
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.8. Macopharma
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.9. Nipro Corporation
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Explore Healthcare Insights
View Reports
Blood Collection Devices Market
